SciELO - Scientific Electronic Library Online

 
vol.62 número3Enfermedad renal crónica agudizada como causa de mortalidad en paciente con COVID-19 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Medicina

versión On-line ISSN 1561-302X

Resumen

SANCHEZ LINARES, Vladimir et al. HeberFERON in Treating Basosquamous Carcinoma. Rev. Cuban de Med [online]. 2023, vol.62, n.3  Epub 01-Sep-2023. ISSN 1561-302X.

Introduction:

Basal squamous cell carcinoma is an aggressive subtype of basal cell carcinoma composed of basaloid cells and areas of squamous cells with an intermediate transition zone, with a tendency to recur and metastasize.

Objective:

To describe the clinical case of a patient with a basal squamous cell carcinoma in the temporal region near the external canthus of the left eye.

Case report:

This paper reports a case of a female patient with a basal squamous cell carcinoma in the temporal region near the external canthus of her left eye with 30 mm diameter. HeberFERON was used with complete response when eliminating the tumor.

Conclusions:

HeberFERON is a non-surgical treatment option that can be used in facial basal squamous cell carcinoma that, due to its size, can cause mutilations or deformities in this area.

Palabras clave : HeberFERON; interferons; basal squamous carcinoma; metatypic carcinoma.

        · resumen en Español     · texto en Español     · Español ( pdf )